Amarin Corp Plc (AMRN)

[jomama9231]

I disagree with you ,respectfully. See case law on Bristol Meyers vs Teva. BMS had 3 secondary considerations in their favor and lost at trial on obviousness. Thoughts on that ?

Therefore I agree with G and others in that we need to win on unexpected benefit which is why I have spent a lot of time on Kurabayashi and the fact errors judge Du committed (and have emailed IR/Covington who actually sent me a thank you message surprisingly)